While Medicare will use blunt instruments to institute payment reform, private payers will be more nimble, causing providers to abandon fee-for-service Medicare in favor of Medicare Advantage.
There is bipartisan support of payment reform, according to Scott Gottlieb, MD, speaking at yesterday's general session. He said the Sustainable Growth Rate bill-which he believes will pass this year-embraces and codifies payment reform.
"That is something that I think is inevitable," Dr. Gottlieb said.
While Medicare will use blunt instruments to institute payment reform, private payers will be more nimble, causing providers to abandon fee-for-service Medicare in favor of Medicare Advantage. However, the private market does tend to follow some of the momentum of Medicare, so he believes that capitation models and bundled payment will be part of both markets.
For health plans, the contours of coverage will bifurcate. Specifically, he envisions profound change coming from employers' desire to move to defined contribution and away from defined benefit. As more workers shift to private exchanges as a result, health plans will design two types of plans: one type for private exchanges and one for the state and federal marketplaces.
And the trend will grow among employer groups.
"The idea that large employers won't move workers to the exchanges is hard to believe," Dr. Gottlieb said. "Once we have certainty around the political dynamic [in 2016], you'll see more employers move those workers into exchanges."
Plans have indicated their private exchange products will resemble Silver metal plans (70% actuarial value). Dr. Gottlieb said the networks will most likely be different between the two platforms.
Republicans will need to propose more details on health reform, especially improvements to the Affordable Care Act (ACA) in the 2016 race. The Patient Choice, Affordability, Responsibility and Empowerment Act, or Patient CARE Act (PCA) is one example of how such reform might be constructed.
"The reality is you can't just repeal ACA," Dr. Gottlieb said. "You have to replace it with something that looks like the ACA structure."
For example, the subsidies now available to families in the working class and low-to-middle income populations are transformative. Consumers who couldn't access healthcare because of premium and out-of-pocket costs now have benefits. Taking that away will not fly politically now.
"Republicans will do much better coming up with a thoughtful plan this time," he said.
For 2016, the number of people who will gain or have gained coverage under one party's policy will not be the top-line comparator as it was with the Obama/McCain race. Rather, the human dimension of access to care and coverage will have more appeal.
"We'll have more Republican politicians talking about access as a moral issue," he said.
In the meantime, the cost of coverage remains a hot-button topic among pundits.
Even though premium increases in 2015 seem like a given, the issue that will cause greater outrage will be the clawback from the IRS for consumers who have income changes that affect their estimated and actual subsidy credit in the exchanges. 2014 subsidies were based on 2013 income. Those who received more generous subsidies than they were entitled to will end up paying back the government.
"I suspect more people will get clawbacks than checks," Dr. Gottlieb said.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More